Healthcare Services Group, Inc. Reports Q3 2022 Results

Rhea-AI Summary

Healthcare Services Group, Inc. (NASDAQ:HCSG) reported a third-quarter revenue of $414.5 million for the period ending September 30, 2022, with a net income of $0.3 million. The Company declared a quarterly cash dividend of $0.215 per common share, marking the 77th consecutive increase since 2003. CEO Ted Wahl noted ongoing industry challenges while emphasizing strategies to improve results in the fourth quarter. The revenue was affected by contract modifications, leading to a $9.0 million reduction in revenue and operating income, with direct service costs reaching 90.9%.

Positive

• 77th consecutive dividend increase since 2003.
• Strategic adjustments expected to improve fourth-quarter results.

Negative

• Revenue impacted by $9.0 million from contract modifications.
• Direct cost of services reached 90.9%, exceeding historical targets.

BENSALEM, Pa.--(BUSINESS WIRE)-- Healthcare Services Group, Inc. (NASDAQ:HCSG) (the “Company”) reported for the three months ended September 30, 2022 revenue of $414.5 million and net income of $0.3 million. The Company’s Board of Directors declared a quarterly cash dividend of $0.215 per common share, the 77^th consecutive increase since the initiation of dividend payments in 2003.

Ted Wahl, Chief Executive Officer, stated, “Our third quarter results reflect the ongoing and expected choppiness that we referenced during our second quarter call. And while we have conviction in our ability to manage the controllable components of our business, we are also realistic about the ongoing challenges that remain within our industry and the broader economy.”

Mr. Wahl continued, “During the quarter, we successfully executed on our strategy to more favorably position our customer partnerships and agreements. We are confident that this work will yield improved results in the fourth quarter and remain on track to meet our goal of exiting the year with cost of services in line with our historical target of 86%.”

Mr. Wahl concluded, “We will continue to adjust, adapt and aim to deliver optimal results for the Company, in a way that maintains the integrity of our existing partnerships, and opportunistically explores prospective new business additions.”

Revenue for the quarter was reported at $414.5 million, with housekeeping & laundry and dining & nutrition segment revenues of $196.9 million and $217.6 million, respectively. As previously disclosed, third quarter results were impacted by contract modification actions taken by the Company, resulting in one-time reductions of approximately $9.0 million in revenue (previously estimated at $17.0 million) and operating income.

Housekeeping & laundry and dining & nutrition segment margins were 8.9% and -0.2%, respectively. Segment margins were impacted by the aforementioned contract modification actions.

Direct cost of services was reported at $376.9 million, or 90.9%. Cost of services was impacted by a $7.6 million increase in AR reserves. The Company remains on track to meet its goal of exiting the year with cost of services in line with its historical target of 86%.

Selling, general and administrative (“SG&A”) was reported at $37.0 million; after adjusting for the $1.2 million decrease in deferred compensation, actual SG&A was $35.8 million, or 8.6%. The Company expects 2022 SG&A to approximate 8.5% to 9.5%.

Cash used in operations for the quarter was $9.9 million and was impacted by a $16.2 million increase in accounts receivable and a $15.7 million decrease in accrued payroll. DSO for the quarter was 76 days.

Dividend

The Company’s Board of Directors declared a quarterly cash dividend of $0.215 per common share, payable on December 22, 2022 to shareholders of record at the close of business on November 18, 2022. This represents the 78^th consecutive quarterly cash dividend payment, as well as the 77^th consecutive increase since the initiation of quarterly cash dividend payments in 2003.

Conference Call and Upcoming Events

The Company will host a conference call on Wednesday, October 19, 2022, at 8:30 a.m. Eastern Time to discuss its results for the three months ended September 30, 2022. The call may be accessed via phone at 1 (888) 330-3451, Conference ID: 4431380. The call will be simultaneously webcast under the “Events & Presentations” section of the Investor Relations page on the Company’s website, www.hcsg.com. A replay of the webcast will also be available on the website for one year following the date of the earnings call.

CAUTIONARY STATEMENT REGARDING FORWARD-LOOKING STATEMENTS

This release and any schedules incorporated by reference into it may contain forward-looking statements within the meaning of federal securities laws, which are not historical facts but rather are based on current expectations, estimates and projections about our business and industry, and our beliefs and assumptions. Words such as “believes,” “anticipates,” “plans,” “expects,” “estimates,” “will,” “goal,” and similar expressions are intended to identify forward-looking statements. The inclusion of forward-looking statements should not be regarded as a representation by us that any of our plans will be achieved. We undertake no obligation to publicly update or revise any forward-looking statements, whether as a result of new information, future events or otherwise. Such forward-looking information is also subject to various risks and uncertainties. Such risks and uncertainties include, but are not limited to, risks arising from our providing services to the healthcare industry, primarily providers of long-term care; the impact of and future effects of the COVID-19 pandemic or other potential pandemics; having a significant portion of our consolidated revenues contributed by one customer during the nine months ended September 30, 2022; credit and collection risks associated with the healthcare industry; our claims experience related to workers’ compensation and general liability insurance (including any litigation claims, enforcement actions, regulatory actions and investigations arising from personal injury and loss of life related to COVID-19); the effects of changes in, or interpretations of laws and regulations governing the healthcare industry, our workforce and services provided, including state and local regulations pertaining to the taxability of our services and other labor-related matters such as minimum wage increases; the Company's expectations with respect to selling, general, and administrative expense; the impact of the concluded Securities and Exchange Commission investigation and related class action lawsuit; heightened volatility of commodity food prices partially due to constrained global production as a result of the Russia-Ukraine conflict and the risk factors described in Part I of our Form 10-K for the fiscal year ended December 31, 2021 under “Government Regulation of Customers,” “Service Agreements and Collections,” and “Competition” and under Item IA. “Risk Factors" in such Form 10K, and in Item 1A. "Risk Factors" of our Form 10-Q for the quarter ended June 30, 2022.

These factors, in addition to delays in payments from customers and/or customers in bankruptcy, have resulted in, and could continue to result in, significant additional bad debts in the near future. Additionally, our operating results would be adversely affected by continued inflation particularly if increases in the costs of labor and labor-related costs, materials, supplies and equipment used in performing services (including the impact of potential tariffs and COVID-19) could not be passed on to our customers.

In addition, we believe that to improve our financial performance we must continue to obtain service agreements with new customers, retain and provide new services to existing customers, achieve modest price increases on current service agreements with existing customers and/or maintain internal cost reduction strategies at our various operational levels. Furthermore, we believe that our ability to sustain the internal development of managerial personnel is an important factor impacting future operating results and the successful execution of our projected growth strategies. There can be no assurance that we will be successful in that regard.

Healthcare Services Group, Inc. is the largest national provider of professional housekeeping, laundry and dietary services to long-term care and related health care facilities.

HEALTHCARE SERVICES GROUP, INC.
CONSOLIDATED STATEMENTS OF INCOME
(Unaudited)
(in thousands, except per share data)
		For the three months ended							For the nine months ended
		September 30,							September 30,
		2022				2021			2022				2021
Revenues		$	414,488			$	415,590		$	1,266,156			$	1,221,512
Operating costs and expenses:
Cost of services provided			376,894				364,822			1,129,526				1,037,852
Selling, general and administrative			35,803				38,780			100,820				128,818
Income from operations			1,791				11,988			35,810				54,842
Other (expense) income, net:
Investment and other (loss) income, net			(798	)			133			(10,786	)			5,294
Income before income taxes			993				12,121			25,024				60,136
Income tax expense			671				2,581			6,553				16,378
Net income		$	322			$	9,540		$	18,471			$	43,758
Basic earnings per common share		$	0.00			$	0.13		$	0.25			$	0.58
Diluted earnings per common share		$	0.00			$	0.13		$	0.25			$	0.58
Cash dividends declared per common share		$	0.21500			$	0.21000		$	0.64125			$	0.62625
Basic weighted average number of common shares outstanding			74,340				74,943			74,334				74,983
Diluted weighted average number of common shares outstanding			74,348				75,076			74,346				75,170

HEALTHCARE SERVICES GROUP, INC.
CONDENSED CONSOLIDATED BALANCE SHEETS
(Unaudited)
(in thousands)
	September 30, 2022			December 31, 2021
Cash and cash equivalents	$	19,633		$	70,794
Marketable securities, at fair value		93,748			114,396
Accounts and notes receivable, net		347,494			293,388
Other current assets		51,818			67,804
Total current assets		512,693			546,382
Property and equipment, net		24,244			28,102
Notes receivable — long-term		26,854			29,259
Goodwill		75,529			74,755
Other intangible assets, net		17,154			20,805
Deferred compensation funding		31,627			46,691
Other assets		34,063			31,535
Total Assets	$	722,164		$	777,529
Accrued insurance claims — current	$	26,242		$	24,310
Other current liabilities		155,580			166,815
Total current liabilities		181,822			191,125
Accrued insurance claims — long-term		69,707			65,084
Deferred compensation liability — long-term		31,807			46,888
Lease liability — long-term		8,748			11,299
Other long term liabilities		8,004			10,456
Stockholders' equity		422,076			452,677
Total Liabilities and Stockholders' Equity	$	722,164		$	777,529

 

View source version on businesswire.com: https://www.businesswire.com/news/home/20221019005336/en/

Theodore Wahl

President and Chief Executive Officer

Matthew J. McKee

Chief Communications Officer

215-639-4274

investor-relations@hcsgcorp.com

Source: Healthcare Services Group, Inc.

FAQ

What was Healthcare Services Group's revenue for Q3 2022?

The revenue for the third quarter of 2022 was $414.5 million.

What is the declared dividend for HCSG for December 2022?

The declared quarterly cash dividend is $0.215 per common share.

How has HCSG's revenue been affected in Q3 2022?

HCSG's revenue was impacted by approximately $9.0 million due to contract modifications.

What challenges did HCSG face in Q3 2022 according to the CEO?

CEO Ted Wahl mentioned ongoing challenges within the industry and the broader economy.

What percentage of direct costs did HCSG report for Q3 2022?

HCSG reported direct costs of services at 90.9%.